NIH Releases Roadmap Details
October 3, 2003 - In an effort to transform the nation's
medical research capabilities and speed the movement of research
discoveries from the bench to the bedside, NIH Director Elias
A. Zerhouni, M.D., Sept. 30 laid out a series of far-reaching
initiatives known collectively as the NIH Roadmap for Medical
Research.
Developed with input from more than 300 nationally recognized
leaders in academia, industry, government and the public,
the NIH Roadmap provides
a framework of the strategic investments that NIH needs to
make to optimize its entire research portfolio. The NIH Roadmap
focuses on the most compelling opportunities in three main
areas: new pathways to discovery, research teams of the future
and re-engineering the clinical research enterprise. Calling
it "a daring effort … to mobilize the leadership
of the NIH and the biomedical research community," AAMC
President Jordan J. Cohen, M.D., issued a statement
supporting the Roadmap.
Dr. Zerhouni also discussed the Roadmap at an Oct. 2 joint
hearing
before the House Energy and Commerce and Senate Health, Education,
Labor and Pensions committees. Also appearing at the hearing
were former NIH Director Harold Varmus, M.D., President and
CEO, Memorial Sloan-Kettering Cancer Center, and Harold Shapiro,
Ph.D., chair of National Academy of Sciences Committee on
the Organizational Structure of the National Institutes of
Health, and President Emeritus and Professor of Economics
and Public Affairs, Department of Economics and Woodrow Wilson
School of Public and International Affairs, Princeton University.
Committee members questioned the witnesses on a variety
of other research issues, including the proposal for commercial
outsourcing under OMB Circular A-76, the status of NIH's stem
cell research efforts, and the decision-making process used
by NIH to support research on politically
Information:
Dave Moore, Senior Associate Vice President
AAMC Government Relations
dbmoore@aamc.org
(202) 828-0525
Get Washington Highlights
in your Inbox!
|
